Emergency blood product administration bears extraordinary risk. The related workflow includes:
- a phone call to the blood bank to initiate product preparation;
- a "Transfuse Emergent Blood Product" order entered by the provider;
- an attestation note completed by the ordering provider.
These actions allow the work of lab and nursing staff to proceed. The attestation confirms that the use of un-crossmatched blood is clinically necessary for patient care.